111 related articles for article (PubMed ID: 7655447)
1. Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension.
Pruszczyk P; Chlebus M
Clin Exp Hypertens; 1995 Jul; 17(5):769-85. PubMed ID: 7655447
[TBL] [Abstract][Full Text] [Related]
2. Hypertensive left ventricular hypertrophy is linked to an enhanced catecholamine response to submaximal exercise.
Kinugawa T; Mori M; Ogino K; Endo A; Kato M; Kato T; Osaki S; Ohtahara A; Igawa O; Hisatome I; Shigemasa C
Eur J Clin Invest; 1999 Jul; 29(7):594-602. PubMed ID: 10411665
[TBL] [Abstract][Full Text] [Related]
3. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
[TBL] [Abstract][Full Text] [Related]
4. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
[TBL] [Abstract][Full Text] [Related]
5. Plasma neuropeptide Y and catecholamines in women and men with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Jedrusik P; Januszewicz A; Lapinski M; Januszewicz W; Zukowska-Grojec Z
Blood Press; 1995 May; 4(3):143-7. PubMed ID: 7670647
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.
Testa A; Mallamaci F; Macrì R; Pisano A; Spoto B; Malatino LS; Stancanelli B; Tripepi G; Benedetto FA; Zoccali C
J Hypertens; 2010 Aug; 28(8):1745-51. PubMed ID: 20543711
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma concentration of neuropeptide Y in adolescents with primary hypertension.
Lettgen B; Wagner S; Hänze J; Lang RE; Rascher W
J Hum Hypertens; 1994 May; 8(5):345-9. PubMed ID: 8064781
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
Chalmers J; Morris M; Kapoor V; Cain M; Elliott J; Russell A; Pilowsky P; Minson J; West M; Wing L
Clin Exp Hypertens A; 1989; 11 Suppl 1():59-66. PubMed ID: 2743605
[TBL] [Abstract][Full Text] [Related]
10. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.
Madsen BK; Husum D; Videbaek R; Stokholm KH; Saelsen L; Christensen NJ
Scand J Clin Lab Invest; 1993 Oct; 53(6):569-76. PubMed ID: 8266002
[TBL] [Abstract][Full Text] [Related]
11. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
Ullman B; Lindvall K; Lundberg JM; Sigurdsson A; Swedberg K
Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
[TBL] [Abstract][Full Text] [Related]
12. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
[TBL] [Abstract][Full Text] [Related]
13. [Neurohumoral factors in hypertensive patients with and without left ventricular hypertrophy].
Karasek E; Witkowska M
Pol Arch Med Wewn; 2000; 103(1-2):23-33. PubMed ID: 11236255
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma neuropeptide Y levels in congestive heart failure.
Maisel AS; Scott NA; Motulsky HJ; Michel MC; Boublik JH; Rivier JE; Ziegler M; Allen RS; Brown MR
Am J Med; 1989 Jan; 86(1):43-8. PubMed ID: 2910096
[TBL] [Abstract][Full Text] [Related]
15. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
[TBL] [Abstract][Full Text] [Related]
16. Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.
Kohno M; Yasunari K; Yokokawa K; Horio T; Kano H; Minami M; Ikeda M; Yoshikawa J
Metabolism; 1996 Nov; 45(11):1326-9. PubMed ID: 8931634
[TBL] [Abstract][Full Text] [Related]
17. Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas.
Eurin J; Barthélemy C; Masson F; Maistre G; Soualmia H; Noé E; Sarfati E; Eurin B; Carayon A
Regul Pept; 2000 Jan; 86(1-3):95-102. PubMed ID: 10672908
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients.
González A; López B; Martín-Raymondi D; Lozano E; Varo N; Barba J; Serrano M; Díez J
J Hypertens; 2005 Dec; 23(12):2297-304. PubMed ID: 16269972
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Pernow J; Lundberg JM; Kaijser L
J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia.
Kaijser L; Pernow J; Berglund B; Lundberg JM
Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
